Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK 61005)
Received: 2 February 2022
Accepted: 1 March 2022
First Online: 10 March 2022
: No human subjects or direct samples were used in this study. The human PC3 prostate cancer cell line is provided with no identifying information. All procedures involving animals were approved by the University of California, Riverside, Institutional Animal Care and Use Committee. A20190048E.
: Not applicable.
: The authors declare that they have no competing interests.